Quick and Effective Pain Relief

The new Ibuprofen Oubari 400 mg, relieves pain and reduces inflammation.

Only Quality, from Our Family to Yours.

For years, quality has been at the heart of our philosophy and operations, helping us become one of the most trusted healthcare companies in the region.

Difficult to Treat Hypertension

Valsartan & Amlodipine Film Coated Tablets in several compositions: 160/5, 160/10, 320/5, and 320/10.

Welcome to Oubari Pharma

Founded in 1989, Oubari for Pharmaceutical Industries (Oubari Pharma) was the first private pharmaceutical company to initiate sterile production in Syria. With a strict focus on quality, Oubari Pharma quickly gained the trust of healthcare professionals and patients. Today, the company has become a leading manufacturer of a wide range of quality generic and licensed pharmaceuticals. It annually provides millions of patients in the MENA region with accessible medication of the highest quality.

More About Us    

Latest Products

Oubari Pharma manufactures a large range of both generic and licensed drugs. We continually aim to develop our product portfolio by identifying the needs of our region’s patients and providing accessible medication of uncompromised quality.

Neomeril Plus 4

Perindopril/Indapamide, Essential hypertension

Metocal – Tablets

Metoclopramide HCl, Anti-emetic

Covert 160/5

Valsartan/Amlodipine, Antihypertensive

Doprane Flu


Recent News

oubari pharma website

Oubari Pharma’s New Website is now Online

| Conferences, Events | No Comments

Oubari Pharma launches its new state of the art website today hoping to provide its visitors with…

vietnam medi-pharm

Oubari Pharma Participates in MEDI-PHARM 2011 in Vietnam

| Conferences, Events | No Comments

MEDIPHARM is an annual exhibition featuring products, equipment, and supplies for the pharmaceutical and health…


Oubari Pharma Launches Neomeril Across Syria

| Conferences, Product News | No Comments

Oubari Pharma held seminars in Aleppo, Damascus, Hama, and Homs where the company introduced NEOMERIL,…


Oubari Pharma Participates in Arab Health 2011

| Conferences, Events | No Comments

Following the success of its first participation at Arab Health in 2006, Oubari Pharma re-visited…